279 related articles for article (PubMed ID: 18276984)
1. Biliverdin reductase: new features of an old enzyme and its potential therapeutic significance.
Florczyk UM; Jozkowicz A; Dulak J
Pharmacol Rep; 2008; 60(1):38-48. PubMed ID: 18276984
[TBL] [Abstract][Full Text] [Related]
2. Small interference RNA-mediated gene silencing of human biliverdin reductase, but not that of heme oxygenase-1, attenuates arsenite-mediated induction of the oxygenase and increases apoptosis in 293A kidney cells.
Miralem T; Hu Z; Torno MD; Lelli KM; Maines MD
J Biol Chem; 2005 Apr; 280(17):17084-92. PubMed ID: 15741166
[TBL] [Abstract][Full Text] [Related]
3. Limited role for the bilirubin-biliverdin redox amplification cycle in the cellular antioxidant protection by biliverdin reductase.
Maghzal GJ; Leck MC; Collinson E; Li C; Stocker R
J Biol Chem; 2009 Oct; 284(43):29251-9. PubMed ID: 19690164
[TBL] [Abstract][Full Text] [Related]
4. Conversion of biliverdin to bilirubin by biliverdin reductase contributes to endothelial cell protection by heme oxygenase-1-evidence for direct and indirect antioxidant actions of bilirubin.
Jansen T; Hortmann M; Oelze M; Opitz B; Steven S; Schell R; Knorr M; Karbach S; Schuhmacher S; Wenzel P; Münzel T; Daiber A
J Mol Cell Cardiol; 2010 Aug; 49(2):186-95. PubMed ID: 20430037
[TBL] [Abstract][Full Text] [Related]
5. Potential application of biliverdin reductase and its fragments to modulate insulin/IGF-1/MAPK/PI3-K signaling pathways in therapeutic settings.
Maines MD
Curr Drug Targets; 2010 Dec; 11(12):1586-94. PubMed ID: 20704544
[TBL] [Abstract][Full Text] [Related]
6. Human biliverdin reductase is a leucine zipper-like DNA-binding protein and functions in transcriptional activation of heme oxygenase-1 by oxidative stress.
Ahmad Z; Salim M; Maines MD
J Biol Chem; 2002 Mar; 277(11):9226-32. PubMed ID: 11773068
[TBL] [Abstract][Full Text] [Related]
7. The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliation.
Barone E; Di Domenico F; Mancuso C; Butterfield DA
Neurobiol Dis; 2014 Feb; 62():144-59. PubMed ID: 24095978
[TBL] [Abstract][Full Text] [Related]
8. The coordinated increased expression of biliverdin reductase and heme oxygenase-2 promotes cardiomyocyte survival: a reductase-based peptide counters β-adrenergic receptor ligand-mediated cardiac dysfunction.
Ding B; Gibbs PE; Brookes PS; Maines MD
FASEB J; 2011 Jan; 25(1):301-13. PubMed ID: 20876213
[TBL] [Abstract][Full Text] [Related]
9. Biliverdin reductase, a novel regulator for induction of activating transcription factor-2 and heme oxygenase-1.
Kravets A; Hu Z; Miralem T; Torno MD; Maines MD
J Biol Chem; 2004 May; 279(19):19916-23. PubMed ID: 14988408
[TBL] [Abstract][Full Text] [Related]
10. Human heme oxygenase-1 efficiently catabolizes heme in the absence of biliverdin reductase.
Reed JR; Huber WJ; Backes WL
Drug Metab Dispos; 2010 Nov; 38(11):2060-6. PubMed ID: 20679134
[TBL] [Abstract][Full Text] [Related]
11. Bilirubin and glutathione have complementary antioxidant and cytoprotective roles.
Sedlak TW; Saleh M; Higginson DS; Paul BD; Juluri KR; Snyder SH
Proc Natl Acad Sci U S A; 2009 Mar; 106(13):5171-6. PubMed ID: 19286972
[TBL] [Abstract][Full Text] [Related]
12. Protein/protein interactions in the mammalian heme degradation pathway: heme oxygenase-2, cytochrome P450 reductase, and biliverdin reductase.
Spencer AL; Bagai I; Becker DF; Zuiderweg ER; Ragsdale SW
J Biol Chem; 2014 Oct; 289(43):29836-58. PubMed ID: 25196843
[TBL] [Abstract][Full Text] [Related]
13. Biliverdin reductase: PKC interaction at the cross-talk of MAPK and PI3K signaling pathways.
Maines MD
Antioxid Redox Signal; 2007 Dec; 9(12):2187-95. PubMed ID: 17919068
[TBL] [Abstract][Full Text] [Related]
14. The heme oxygenase/biliverdin reductase pathway in drug research and development.
Mancuso C; Barone E
Curr Drug Metab; 2009 Jul; 10(6):579-94. PubMed ID: 19702533
[TBL] [Abstract][Full Text] [Related]
15. Redox Functions of Heme Oxygenase-1 and Biliverdin Reductase in Diabetes.
Rochette L; Zeller M; Cottin Y; Vergely C
Trends Endocrinol Metab; 2018 Feb; 29(2):74-85. PubMed ID: 29249571
[TBL] [Abstract][Full Text] [Related]
16. Biliverdin reductase as a target in drug research and development: Facts and hypotheses.
Mancuso C
Free Radic Biol Med; 2021 Aug; 172():521-529. PubMed ID: 34224815
[TBL] [Abstract][Full Text] [Related]
17. Enhanced neuronal expression of the oxidoreductase--biliverdin reductase--after permanent focal cerebral ischemia.
Panahian N; Huang T; Maines MD
Brain Res; 1999 Dec; 850(1-2):1-13. PubMed ID: 10629743
[TBL] [Abstract][Full Text] [Related]
18. The presence of heme-oxygenase and biliverdin reductase in human cranial ganglia indicates a role for carbon monoxide in neural transmission.
Uddman R; Tajti J; Sundler F; Cardell LO
Neuro Endocrinol Lett; 2004 Dec; 25(6):423-8. PubMed ID: 15665804
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical localization of the antioxidant enzymes biliverdin reductase and heme oxygenase-2 in human and pig gastric fundus.
Colpaert EE; Timmermans JP; Lefebvre RA
Free Radic Biol Med; 2002 Apr; 32(7):630-7. PubMed ID: 11909697
[TBL] [Abstract][Full Text] [Related]
20. Overview of heme degradation pathway.
Maines MD
Curr Protoc Toxicol; 2001 May; Chapter 9():Unit 9.1. PubMed ID: 23045067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
